Q
QUANTUM X LABS INC.
QXLCIK 0000797542NasdaqNon-AcceleratedSmaller ReportingServices-Prepackaged SoftwareDelawareFY ends Dec 31
Period
FY 2025
Revenue
—
Net Income
$-19.29M
Total Assets
$10.76M
Equity
$4.99M
Shares Out
13.34M
Op. Cash Flow
$-2.77M
Business
Viewbix Inc. operates a diversified digital technology and emerging technology company. The company's primary segment is Gix Media's Search Platform, which automates and monetizes digital advertising campaigns through browser add-ons and search-referral models. Viewbix also develops quantum algorithms and technologies through its Quantum X Labs subsidiary across transportation, drug discovery, security, and sensing applications, and offers AI-powered writing assistance tools through Metagramm. The company operates globally serving search engines, enterprise customers, and individual users.
Summary from 10-K filed 2026-03-27
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Revenues | 2 | 5 | — | — | — | |
| Traffic-acquisition and related costs | 297,000 | 2 | 70 | 166,000 | 222,000 | |
| Research and development | 69,000 | 830,000 | 3 | 3 | 2 | |
| Selling and marketing | 100,000 | 309,000 | 3 | 2 | 1 | |
| General and administrative | 2 | 2 | 3 | 2 | 1 | |
| Depreciation and amortization | 848,000 | 813,000 | 3 | 3 | 2 | |
| Other expenses, net | 814,000 | 271,000 | — | — | — | |
| Operating loss | 2 | 837,000 | 7 | 3 | 541,000 | |
| Financial expense, net | 11 | 3 | 1 | — | — | |
| Loss from continuing operations, before taxes | 13 | 3 | 9 | 1 | 681,000 | |
| Income tax expense (benefit) | −39,000 | 131,000 | −66,000 | 153,000 | 90,000 | |
| Net loss from continuing operations | 13 | 4 | — | — | — | |
| Net loss from discontinued operations | 7 | 11 | — | — | — | |
| Net loss | 21 | 14 | 9 | 1 | 591,000 | |
| Less: net loss attributable to non-controlling interests | 2 | 2 | 1 | 1 | 291,000 | |
| Net loss attributable to shareholders of Viewbix Inc. | 19 | 12 | 7 | 28,000 | 300,000 | |
| Shareholders of Viewbix Inc. | 13 | 4 | — | — | — | |
| Non-controlling interests | — | — | — | — | — | |
| Shareholders of Viewbix Inc. | 6 | 8 | — | — | — | |
| Non-controlling interests | 2 | 2 | — | — | — | |
| Net loss per share from continuing operations - Basic attributed to shareholders | 1.58 | 0.8 | — | — | — | |
| Net loss per share from continuing operations - Diluted attributed to shareholders | 1.58 | 0.8 | — | — | — | |
| Net loss per share from discontinued operations - Basic attributed to shareholders | 0.69 | 1.89 | — | — | — | |
| Net loss per share from discontinued operations - Diluted attributed to shareholders | 0.69 | 1.89 | — | — | — | |
| Total net loss per share - Basic attributed to shareholders | 2.28 | 2.69 | 1.97 | 0 | 0.02 | |
| Total net loss per share - Diluted attributed to shareholders | 2.28 | 2.69 | 1.97 | 0 | — | |
| Weighted average number of shares - Basic | 8 | 4 | 4 | 15 | 15 | |
| Weighted average number of shares - Diluted | 8 | 4 | 4 | 15 | 15 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 1 | 24,000 | 2 | 4 | 5 | |
| Restricted deposits | 20,000 | 30,000 | 149,000 | — | — | |
| Accounts receivable | 315,000 | 557,000 | 11 | 21 | 16 | |
| Loan to parent company | — | 4 | 4 | 4 | — | |
| Other current assets | 299,000 | 775,000 | 771,000 | 973,000 | 1 | |
| Current assets of discontinued operations | — | 2 | — | — | — | |
| Total current assets | 2 | 8 | 18 | 30 | 29 | |
| Deferred taxes | 12,000 | 56,000 | 147,000 | 340,000 | 133,000 | |
| Property and equipment, net | 56,000 | 17,000 | 245,000 | 302,000 | 334,000 | |
| Financial assets measured at cost method | 600,000 | — | — | — | — | |
| Intangible assets, net | 2 | 2 | 12 | 15 | 8 | |
| Goodwill | 6 | 1 | 12 | 17 | 12 | |
| Non-current assets of discontinued operations | — | 11 | — | — | — | |
| Total non-current assets | 9 | 14 | 25 | 34 | 22 | |
| Total assets | 11 | 22 | 43 | 64 | 51 | |
| Accounts payable | 1 | 2 | 12 | 20 | 17 | |
| Short-term loans | 260,000 | 1 | 5 | 5 | 5 | |
| Current maturities of long-term loans | 781,000 | 3 | 1 | 2 | — | |
| Embedded derivatives | — | 29,000 | — | — | — | |
| Short-term convertible loans | 867,000 | 779,000 | — | — | — | |
| Other payables | 951,000 | 597,000 | — | — | — | |
| Current liabilities of discontinued operations | — | 5 | — | — | — | |
| Total current liabilities | 4 | 13 | 20 | 29 | 27 | |
| Long-term loans, net of current maturities | 586,000 | 496,000 | 3 | 3 | 4 | |
| Deferred taxes | 326,000 | 222,000 | 2 | 2 | 1 | |
| Earn-out liability | 793,000 | — | — | — | — | |
| Non-current liabilities of discontinued operations | — | 812,000 | — | — | — | |
| Total non-current liabilities | 2 | 2 | 5 | 5 | 6 | |
| Commitments and Contingencies | — | — | — | — | — | |
| Common stock of $0.0001 par value - Authorized: 490,000,000 shares; Issued and outstanding: 10,670,392 and 5,296,945 shares as of December 31, 2025, and December 31, 2024, respectively . | 4,000 | 3,000 | 3,000 | 3,000 | 3,000 | |
| Additional paid-in capital | 51 | 28 | 25 | 25 | 16 | |
| Accumulated deficit | −46 | −23 | −11 | −3 | −2 | |
| Equity attributed to shareholders of Viewbix Inc. | 5 | 6 | 15 | 22 | 14 | |
| Non-controlling interests | — | 2 | 4 | 8 | 5 | |
| Total equity | 5 | 8 | 19 | 30 | 19 | |
| Total liabilities and shareholders equity | 11 | 22 | 43 | 64 | 51 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Share-based compensation | 75,000 | 69,000 | 135,000 | 71,000 | −43,000 | |
| Deferred taxes | −68,000 | −40,000 | — | — | — | |
| Accrued interest, net | 23,000 | 33,000 | — | 67,000 | −135,000 | |
| Interest income | −63,000 | −160,000 | −87,000 | −143,000 | — | |
| Amortization of loan discounts | 38,000 | 59,000 | 9,000 | — | — | |
| Change in the fair value of financial liabilities at fair value through profit or loss (see note 12) | 10 | −11,000 | — | — | — | |
| Amortization of deferred debt issuance costs (see notes 11.D, 11.E, 11.F) | 632,000 | 152,000 | — | — | — | |
| Equity based debt issuance costs (see note 11.D) | — | 26,000 | — | — | — | |
| Loss from substantial debt terms modification (see note 11.C) | — | 2 | — | — | — | |
| Loss on sale and disposal of property and equipment | — | 73,000 | — | — | — | |
| Loss from termination of lease agreement | — | 8,000 | — | — | — | |
| Decrease in accounts receivable | 297,000 | 2 | 10 | −5 | 498,000 | |
| Decrease (increase) in other current assets | −153,000 | 319,000 | 202,000 | −52,000 | — | |
| Decrease in accounts payable | −1 | −372,000 | −7 | 3 | 2 | |
| Increase in other payables | 322,000 | 128,000 | −620,000 | 177,000 | −649,000 | |
| Net cash provided by (used in) operating activities from continuing operations | −3 | 1 | — | — | — | |
| Net cash from acquisition of a subsidiary (see appendix A) | 12,000 | — | — | — | — | |
| Net cash from deconsolidation of a subsidiary (see appendix B) | −163,000 | — | — | — | — | |
| Net cash used in investing activities from continuing operations | −151,000 | — | — | — | — | |
| Receipt of short-term bank loans | 8 | 935,000 | 1 | — | — | |
| Receipt of short-term convertible loans | 630,000 | 630,000 | — | — | 4 | |
| Repayment of short-term bank loans | −9 | −3 | −1 | — | — | |
| Receipt of a long-term bank loan (see note 11.B) | 2 | — | — | — | — | |
| Repayment of long-term bank loans | −4 | −510,000 | −2 | −1 | −230,000 | |
| Increase in loan to parent company | −4,000 | −69,000 | −123,000 | −1 | −199,000 | |
| Proceeds from issuance of shares and warrants in connection with 2024 Private Placement, net of issuance costs (see note 15.B) | — | 198,000 | — | — | — | |
| Proceeds from issuance of shares and warrants in connection with July 2025 Private Placement, net of issuance costs (see note 15.C) | 4 | — | — | — | — | |
| Proceeds from exercise of warrants | 2 | — | — | — | — | |
| Net cash provided by (used in) financing activities from continuing operations | 4 | −2 | — | — | — | |
| Net cash provided by (used in) operating activities from discontinued operations | −694,000 | 143,000 | — | — | — | |
| Net cash used in investing activities from discontinued operations | — | −1,000 | — | — | — | |
| Net cash provided by (used in) financing activities from discontinued operations | 170,000 | −670,000 | — | — | — | |
| Net cash used in discontinued operations | −524,000 | −528,000 | — | — | — | |
| Increase (decrease) in cash and cash equivalents and restricted cash | 356,000 | −1 | −2 | −1 | 2 | |
| Taxes paid | −8,000 | −123,000 | −663,000 | −928,000 | −381,000 | |
| Interest paid | −405,000 | −676,000 | −922,000 | −556,000 | −84,000 | |
| Total Cash paid during the period | −413,000 | −799,000 | −2 | −1 | — | |
| Deemed extinguishment and re-issuance of debt (see note 11.C) | — | 500,000 | — | — | — | |
| Termination of operating lease agreement (see note 6) | — | 389,000 | — | — | — | |
| Redemption of loan to parent company (see note 17) | 4 | — | — | — | — | |
| Conversion of loans into shares and warrants (see notes 11.D, 11.E, 11.F) | 922,000 | — | — | — | — | |
| Investment in shares received in connection with deconsolidation of Cortex (see note 8.B) | 600,000 | — | — | — | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Frequently asked questions
What is QUANTUM X LABS INC.'s CIK number?
QUANTUM X LABS INC.'s SEC CIK number is 0000797542 (797542). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find QUANTUM X LABS INC.'s SEC filings?
All of QUANTUM X LABS INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.